Role of blood coagulation factor XI in downregulation of fibrinolysis.
Factor XI is a component of the intrinsic pathway of coagulation. A deficiency of factor XI is associated with a mild to moderate bleeding disorder especially from tissues with a high local fibrinolytic activity. In contrast, high levels of factor XI are a risk factor for venous thrombosis. The recent finding that factor XI can be activated by thrombin led to a revised model of coagulation. In this model the primary thrombin generation that results in fibrin formation takes place via the extrinsic pathway. Additional thrombin generation takes place inside the fibrin clot via the intrinsic pathway after the activation of factor XI by thrombin. High concentrations of thrombin are formed that are necessary for the activation of thrombin activatable fibrinolysis inhibitor (TAFI). Activated TAFI protects the fibrin clot against lysis. The role of factor XI in hemostasis can therefore be seen as a combination of procoagulant and antifibrinolytic actions. The new insights in the role of factor XI in coagulation and fibrinolysis may lead to new strategies for the treatment of thrombotic disorders.
Bouma
B N
BN
Department of Haematology, University Medical Center, Utrecht, The Netherlands. B.N.Bouma@lab.azu.nl
Meijers
J C
JC
D000818:Animals; D015536:Down-Regulation / Q000187:drug effects; D005172:Factor XI / Q000494:pharmacology / Q000502:physiology*; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D013917:Thrombin / Q000096:biosynthesis / Q000378:metabolism; D020246:Venous Thrombosis / Q000209:etiology
D005172:Factor XI; D013917:Thrombin